Literature DB >> 17466080

Acute renal failure in patients with sepsis.

José António Lopes, Sofia Jorge, Cristina Resina, Carla Santos, Alvaro Pereira, José Neves, Francisco Antunes, Mateus Martins Prata.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17466080      PMCID: PMC2206468          DOI: 10.1186/cc5735

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.

The evaluation of acute renal failure (ARF) by the newly developed classification for ARF (RIFLE, standing for 'risk, injury, failure, loss, end-stage kidney disease') [1] in patients with sepsis has not yet been performed. We evaluated, retrospectively, the incidence of ARF and its risk factors, therapy, and outcome among patients with sepsis admitted to the Infectious Diseases Intensive Care Unit of the Hospital de Santa Maria between January 2005 and December 2006. ARF was defined by means of the RIFLE classification [1]. Sepsis was classified in accordance with the American College of Chest Physicians and the Society of Critical Care Medicine consensus [2]. In all, 182 patients (aged 56.2 ± 18.56 years (mean ± SD), 120 male, 162 Caucasian) were analyzed. Baseline characteristics of the patients are summarized in Table 1. Sixty-eight patients (37.4%) had ARF. By multivariate analysis, age more than 60 years (odds ratio (OR) 0.39, 95% confidence interval (CI) 0.17 to 0.87, P = 0.002), male (OR 5.5, 95% CI 2.2 to 13.5, P < 0.0001), chronic kidney disease (OR 0.2, 95% CI 0.06 to 0.79, P = 0.021), Gram-negative-related infection (OR 0.38, 95% CI 0.16 to 0.89, P = 0.027), and a Simplified Acute Physiology Score, version II (SAPS II) > 50 (OR 0.14, 95% CI 0.06 to 0.31, P < 0.0001) were independently associated with ARF. Thirteen patients (3 with injury and 10 with renal failure) had received renal replacement therapy (12 receiving continuous venovenous hemodiafiltration, and 1 receiving intermittent hemodialysis). The mortality rate was 37.4%, and increased from 'normal' to 'failure'. Patients who did not die had renal function recovery. Multivariate analysis including age more than 60 years, gender, SAPS II > 50, comorbidity (namely cardiovascular disease), and ARF showed that SAPS II > 50 (OR 0.12, 95% CI 0.05 to 0.29, P < 0.0001) and ARF (OR 0.26, 95% CI 0.11 to 0.63, P = 0.003) were independent predictors of mortality.
Table 1

Baseline characteristics

VariableNo AKIRiskInjuryFailureP
n114112136
Age (years)a54 ± 18.261.9 ± 20.961.6 ± 13.461.8 ± 16.3NS
Sex (male)65 (57)10 (91)18 (85.7)27 (75)0.009
Race (Caucasian)102 (89.5)10 (91)20 (95.2)30 (83.3)NS
Severe sepsisb77 (67.5)6 (54.5)12 (57.1)13 (36.1)0.012
Septic shockb25 (21.9)4 (36.4)8 (38)23 (64)<0.0001
CVD37 (32.4)3 (27.3)10 (47.6)14 (38.9)NS
CKD5 (43.9)1 (9)4 (19)8 (22.2)0.009
SAPS II > 5022 (19.3)6 (54.5)7 (33.3)9 (26.5)0.06
Mortality11 (9.6)3 (27.3)6 (28.6)20 (55)<0.0001

Figures in parentheses are percentages. AKI, acute kidney injury; CKD, chronic kidney disease; CVD, cardiovascular disease, diabetes mellitus and hypertension; NS, not significant; SAPS II, Simplified Acute Physiology Score, version II. The SAPS II was calculated on the basis of the worst variables recorded during the first 24 hours of ICU admission. aMeans ± SD; bsepsis was classified in accordance with American College of Chest Physicians and the Society of Critical Care Medicine consensus [2].

Baseline characteristics Figures in parentheses are percentages. AKI, acute kidney injury; CKD, chronic kidney disease; CVD, cardiovascular disease, diabetes mellitus and hypertension; NS, not significant; SAPS II, Simplified Acute Physiology Score, version II. The SAPS II was calculated on the basis of the worst variables recorded during the first 24 hours of ICU admission. aMeans ± SD; bsepsis was classified in accordance with American College of Chest Physicians and the Society of Critical Care Medicine consensus [2]. Thus, ARF as determined by RIFLE is common among patients with sepsis, and increases mortality. Age, gender, chronic kidney disease, Gram-negative-related infection and severity of illness are independently associated with ARF in this setting.

Abbreviations

ARF = acute renal failure; CI = confidence interval; OR = odds ratio; RIFLE = risk, injury, failure, loss, end-stage kidney disease; SAPS II = Simplified Acute Physiology Score, version II.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

JAL, SJ, CR, and CS made substantial contributions to the conception and design of the study, to the acquisition of data, and to the analysis and interpretation of data. JAL, CR, AP, JN, FA, and MMP were involved in drafting the manuscript and revising it critically for important intellectual content. All authors read and approved the final manuscript.
  2 in total

Review 1.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

Review 2.  Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.

Authors:  Rinaldo Bellomo; Claudio Ronco; John A Kellum; Ravindra L Mehta; Paul Palevsky
Journal:  Crit Care       Date:  2004-05-24       Impact factor: 9.097

  2 in total
  24 in total

Review 1.  Surgical sepsis and organ crosstalk: the role of the kidney.

Authors:  Laura E White; Rahul Chaudhary; Laura J Moore; Frederick A Moore; Heitham T Hassoun
Journal:  J Surg Res       Date:  2010-12-30       Impact factor: 2.192

2.  Cardiorenal syndromes.

Authors:  Peter A McCullough; Aftab Ahmad
Journal:  World J Cardiol       Date:  2011-01-26

3.  Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease.

Authors:  Rong Chu; Cui Li; Suxia Wang; Wanzhong Zou; Gang Liu; Li Yang
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 8.237

4.  Interleukin-1β suppresses activity of an inwardly rectifying K+ channel in human renal proximal tubule cells.

Authors:  Kazuyoshi Nakamura; You Komagiri; Manabu Kubokawa
Journal:  J Physiol Sci       Date:  2013-09       Impact factor: 2.781

5.  Alpha1-microglobulin as an early biomarker of sepsis-associated acute kidney injury: a prospective cohort study.

Authors:  I Terzi; V Papaioannou; N Papanas; C Dragoumanis; A Petala; V Theodorou; T Gioka; V Vargemezis; E Maltezos; I Pneumatikos
Journal:  Hippokratia       Date:  2014 Jul-Sep       Impact factor: 0.471

6.  The incidence, risk factors, and outcomes of acute kidney injury in patients with pyogenic liver abscesses.

Authors:  Seong Eun Yun; Dae-Hong Jeon; Min Jeong Kim; Eun Jin Bae; Hyun Seop Cho; Se-Ho Chang; Dong Jun Park
Journal:  Clin Exp Nephrol       Date:  2014-08-05       Impact factor: 2.801

7.  Sepsis-induced acute kidney injury.

Authors:  Arghya Majumdar
Journal:  Indian J Crit Care Med       Date:  2010-01

Review 8.  Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury.

Authors:  Suzanne Heemskerk; Rosalinde Masereeuw; Frans G M Russel; Peter Pickkers
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

9.  Procalcitonin levels predict acute kidney injury and prognosis in acute pancreatitis: a prospective study.

Authors:  Hua-Lan Huang; Xin Nie; Bei Cai; Jiang-Tao Tang; Yong He; Qiang Miao; Hao-Lan Song; Tong-Xing Luo; Bao-Xiu Gao; Lan-Lan Wang; Gui-Xing Li
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

10.  Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative.

Authors:  Claudio Ronco; Peter McCullough; Stefan D Anker; Inder Anand; Nadia Aspromonte; Sean M Bagshaw; Rinaldo Bellomo; Tomas Berl; Ilona Bobek; Dinna N Cruz; Luciano Daliento; Andrew Davenport; Mikko Haapio; Hans Hillege; Andrew A House; Nevin Katz; Alan Maisel; Sunil Mankad; Pierluigi Zanco; Alexandre Mebazaa; Alberto Palazzuoli; Federico Ronco; Andrew Shaw; Geoff Sheinfeld; Sachin Soni; Giorgio Vescovo; Nereo Zamperetti; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2009-12-25       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.